Home / Media Center / News

Search

PFIZER’S NURTEC RECEIVES TOP RANKING IN 2023 TGAS DIGITAL MARKETING COMPETENCY REPORT

Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a brand digital competency ranking. Brands that topped the 2023 Digital Marketing Competency Report’s list include: Pfizer’s Nurtec Idorsia’s Quviviq…

Read Now

TRINITY LIFE SCIENCES MAPS OUT INVESTMENT STRATEGIES AND TACTICS TO CALIBRATE A PATIENT-CENTRIC APPROACH IN RARE DISEASE

New Advisory Brief Discusses Four Pillars to Focus Resource Allocation, Improve Patient Care and Provide Differentiated Patient Partnership Waltham, MA, November 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief outlines four pillars that focus resource allocation, improve patient care and provide differentiated patient partnership. Within the nuances of each disease, companies must effectively…

Read Now

TRINITY LIFE SCIENCES NAMES FIRST CHIEF TECHNOLOGY OFFICER

Rajeev Rangachari Plans to Bolster a Culture of Innovation Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity. As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets.…

Read Now

TRINITY LIFE SCIENCES USES NEW “TETHERED” APPROACH TO INTEGRATE HCP-LEVEL REAL-WORLD DATA AND IMPROVE BRAND SHARE ESTIMATES

New White Paper Maps Out Method that Significantly Improves Prediction of Future Prescribing Behavior in Demand Studies Waltham, MA, October 11, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces the first method that incorporates Healthcare Professionals (HCP)-specific real-world behaviors to improve share calibration for forecasting.  The method, called “tethering,” uses real-world prescribing behaviors to calibrate share estimates from primary market research (PMR) by connecting them to the current market scenario. This real-world calibration at…

Read Now

NEW WHITE PAPER REVEALS THE GOOD, THE BAD AND THE UGLY ON THE JOURNEY TO FULL GLOBALIZATION FOR PHARMA COMMERCIAL OPERATIONS TEAMS

Waltham, MA, October 9, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ white paper “The Globalization Marathon: Is Pharma Commercial Operations Moving to a Full Global Operating Model?” The white paper is based on primary research conducted by TGaS with a subset of its ~100 member companies’ Commercial Operations leaders representing large, mid-size and emerging pharmaceutical companies operating in global markets. The research found that most organizations are not…

Read Now

TRINITY LIFE SCIENCES INTRODUCES LAUNCH ACCELERATOR 2.0, THE FIRST AND ONLY BENCHMARK-BASED LAUNCH TOOL FOR PHARMA

New White Paper Analyzes Launches Since the Start of the COVID Pandemic to Profile Key Strategies that Improve Commercialization Success Waltham, MA, October 2, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of Trinity Launch Accelerator 2.0 to provide smart, efficient launch planning with customized, tech-enabled support. Built and powered by Trinity’s Launch Center of Excellence (COE), Launch Accelerator 2.0 is an easy-to-use cloud-based project management tool that leverages recent “real world”…

Read Now

TRINITY LIFE SCIENCES APPOINTS ADVISORY BOARD

Waltham, MA, September 20, 2023 —  Trinity Life Sciences, a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission. The Board of Advisors includes: Susan DenmanMs. Denman is formerly with Johnson & Johnson where she held senior management roles including WW Vice President of Transfusion Medicine, WW VP of Innovation for Ortho Clinical Diagnostics, WW VP for the $2.4B Johnson’s Baby business, WW VP of…

Read Now

TRINITY LIFE SCIENCES RECOGNIZED IN GARTNER® HYPE CYCLE™ FOR LIFE SCIENCES COMMERCIAL OPERATIONS, 2023

Waltham, MA, August 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, was identified as a Sample Vendor in four sections within the July 2023 Gartner Hype Cycle for Life Sciences Commercial Operations report. The sections where Trinity was named are: AI (Artificial Intelligence) in Commercial Operations Advanced Decision Support for Sales Personalization Engines in LS (Life Science) D&A (Data & Analytics) Platforms in Commercial LS As Gartner explains: “Life science organizations strive to balance…

Read Now

TRINITY LIFE SCIENCES NAMED TO THE INC. 5000 LIST FOR THE THIRD YEAR IN A ROW

Waltham, MA, August 15, 2023 —  Inc. revealed today that Trinity Life Sciences, a leader in global life sciences commercialization solutions, was named to the Inc. 5000 list for the third year in a row. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment – its independent, entrepreneurial businesses. “We are thrilled to again be named to the Inc. 5000 list of fastest growing private companies in America,” said Leslie Orne,…

Read Now

TRINITY LIFE SCIENCES EVALUATES COMMERCIAL PERFORMANCE OVER 3 YEARS OF 53 NOVEL DRUGS APPROVED IN 2019

Trinity Annual Drug Index Now Available Waltham, MA, July 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the availability of its Trinity Annual Drug Index, an evaluation of the actual commercial performances over 3 years of 53 novel drugs approved in 2019. This year’s report, the fifth in Trinity’s Drug Index series, outlines key themes and emerging trends as the life sciences industry moves towards a new world of targeted and innovative products. Scoring…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.